In addition, antisense lncRNA-IRAIN, which is transcribed from the insulin-like growth factor type I receptor serving as the gene locus, plays a negative regulatory role in high-risk AML patients [26]. The gene discussed is IRAIN; the disease is acute myeloid leukemia.